The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000156.6(GAMT):c.54C>T (p.Pro18=)

CA304067345

696471 (ClinVar)

Gene: GAMT
Condition: guanidinoacetate methyltransferase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: efb12c0e-8b6f-47be-95ec-ef9fbdd2c49e

HGVS expressions

NM_000156.6:c.54C>T
NM_000156.6(GAMT):c.54C>T (p.Pro18=)
NC_000019.10:g.1401423G>A
CM000681.2:g.1401423G>A
NC_000019.9:g.1401422G>A
CM000681.1:g.1401422G>A
NC_000019.8:g.1352422G>A
NG_009785.1:g.5131C>T
ENST00000252288.8:c.54C>T
ENST00000447102.8:c.54C>T
ENST00000640762.1:c.54C>T
ENST00000252288.6:c.54C>T
ENST00000447102.7:c.54C>T
NM_000156.5:c.54C>T
NM_138924.2:c.54C>T
NM_138924.3:c.54C>T

Likely Benign

The Expert Panel has overridden the computationally generated classification - "Uncertain Significance - Conflicting Evidence"
Met criteria codes 3
PM2_Supporting BP7 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GAMT Version 1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Cerebral Creatine Deficiency Syndromes VCEP
The NM_000156.6:c.54C>T (p.Pro18=) variant in GAMT is a synonymous variant in exon 1 which is predicted to not impact splicing by SpliceAI and VarSeak, and the nucleotide is not highly conserved (BP4, BP7). The highest population minor allele frequency in a continental population of >2,000 alleles is 0.00008 in the non-Finnish European population, which is lower than the ClinGen CCDS VCEP’s threshold for PM2_Supporting (<0.0004). The site is covered in fewer than 50% of individuals in gnomAD v2.1.1 exomes, and therefore the allele frequency estimates may not be reliable but PM2_Supporting. This variant does not appear to have been previously reported in the published literature. However, it is noted in ClinVar (Variation ID: 696471). Although this variant may be rare, it has been classified as likely benign by the ClinGen CCDS VCEP based on the recommendation of Richards et al (PMID: 25741868) because it is a synonymous variant, the altered nucleotide is not highly conserved, computational prediction suggests no impact on splicing, and there is no additional evidence to suggest that the variant is disease-causing. GAMT-specific ACMG/AMP criteria applied, as specified by the CCDS VCEP (Specifications Version 1.1.0): PM2_Supporting, BP4, BP7. (Classification approved by the ClinGen CCDS VCEP on June 6, 2022).
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in a continental population of >2,000 alleles is 0.00008 in the non-Finnish European population, which is lower than the ClinGen CCDS VCEP’s threshold for PM2_Supporting (<0.0004), meeting this criterion. However, the site is covered in fewer than 50% of individuals in gnomAD v2.1.1 exomes, and therefore the allele frequency estimates may not be reliable.
BP7
It is predicted to not impact splicing by SpliceAI and VarSeak, and the nucleotide is not highly conserved (GERP rejected substitutions (RS) score -3.71) (BP7).
BP4
It is predicted to not impact splicing by SpliceAI and VarSeak (BP4).
Approved on: 2022-06-06
Published on: 2022-10-07
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.